USPTO serial 97359672
MRIDIAN A3I
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 3, 2026
- Examiner
- BELL, MARLENE D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MRIDIAN A3I?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DENVER, CO, US
DENVER, CO, US
Oakwood Village, OH, US
Oakwood Village, OH, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer hardware for use with an adaptive radiotherapy medical apparatus and systems for receiving, processing, transmitting, and displaying data; computer hardware for processing and analyzing magnetic resonance images (MRI); computer hardware for use with a magnetic resonance imaging (MRI) diagnostic apparatus for receiving, processing, analyzing, transmitting, and displaying information for clinical, laboratory, or research use; computer hardware for use with a radiotherapy apparatus for collecting, processing, transmitting, analyzing, and displaying data; computer hardware for use with radiotherapy apparatus to collect, process, transmit, analyze, and display patient data for purposes of planning and delivering treatment to that patient; computer hardware for the creation or transmission of audio, video and data related to a medical treatment for diagnostic, clinical, laboratory, or research use; computer hardware for communicating audio, video and data, namely, magnetic resonance images (MRI) and radiotherapy treatment information, between computers via a global computer network, wide-area computer networks, and peer-to-peer computer networks; recorded software for use with an adaptive radiotherapy medical apparatus and systems for receiving, processing, transmitting, and displaying data; recorded software for processing and analyzing magnetic resonance images (MRI); recorded software for use with a magnetic resonance imaging (MRI) diagnostic apparatus for receiving, processing, analyzing, transmitting, and displaying information for clinical, laboratory, or research use; recorded software for use with a radiotherapy apparatus for collecting, processing, transmitting, analyzing, and displaying data; recorded software for use with radiotherapy apparatus to collect, process, transmit, analyze, and display patient data for purposes of planning and delivering treatment to that patient; recorded software for the creation or transmission of audio, video and data related to a medical treatment for diagnostic, clinical, laboratory, or research use; recorded software for communicating audio, video and data, namely, magnetic resonance images (MRI) and radiotherapy treatment information, between computers via a global computer network, wide-area computer networks, and peer-to-peer computer networks; downloadable computer software for processing magnetic resonance imaging (MRI) data that may be downloaded to a global computer network for analysis; downloadable computer software to enable healthcare professionals to remotely access, analyze, transmit, display, and collaborate on data derived from an MRI diagnostic apparatus; downloadable computer software for use in remote computer access and collaboration by healthcare professionals for processing and analyzing magnetic resonance images (MRI); downloadable computer software for use in remote computer access for the creation or transmission of audio, video and data related to a medical treatment for diagnostic or clinical use via private cloud computing for medical professionals to work collaboratively; downloadable computer software for use in remote computer access for communicating audio, video and data, namely, magnetic resonance images (MRI) and radiotherapy treatment information, between computers via a secure global computer network, wide-area computer networks, and peer-to-peer computer networks; downloadable computer software that enables healthcare professionals to simultaneously and collaboratively access, analyze, transmit, and display patient data obtained from a radiotherapy apparatus remotely; downloadable computer software for use by healthcare professionals to enable the simultaneous and collaborative remote access to on-table adaptive radiotherapy medical apparatus and systems for purposes of directing and modifying radiotherapy treatments, treatment plans, and treatment delivery | ACTIVE | — |
| 042 | Software as a service (SaaS) services featuring software for use with an adaptive radiotherapy medical apparatus and systems for receiving, processing, transmitting and displaying data; software as a service (SaaS) services featuring software for processing and analyzing magnetic resonance images (MRI); software as a service (SaaS) services featuring software for use with magnetic resonance imaging (MRI) diagnostic apparatus for receiving, processing, analyzing, transmitting and displaying information; software as a service (SaaS) services featuring software for use with a radiotherapy apparatus for collecting, processing, transmitting, analyzing, and displaying data; software as a service (SaaS) services featuring software for use with radiotherapy apparatus to collect, process, transmit, analyze, and display patient data for purposes of planning and delivering treatment to that patient; software as a service (SaaS) services featuring software for use in the creation or transmission of audio, video and data related to a medical treatment for diagnostic or clinical use; software as a service (SaaS) services featuring software for communicating audio, video and data, namely, magnetic resonance images (MRI) and radiotherapy treatment information, between computers via a global computer network, wide-area computer networks, and peer-to-peer computer networks; software as a service (SaaS) services featuring software for use with processing magnetic resonance imaging (MRI) data that may be downloaded to a global computer network for analysis; software as a service (SaaS) services featuring software to enable healthcare professionals to remotely access, analyze, transmit, display, and collaborate on data derived from an MRI diagnostic apparatus; software as a service (SaaS) services featuring software for use in remote computer access and collaboration by healthcare professionals for processing and analyzing magnetic resonance images (MRI); software as a service (SaaS) services featuring software for use in remote computer access and collaboration by healthcare professionals of MRI diagnostic apparatus for receiving, processing, analyzing, transmitting and displaying information; software as a service (SaaS) services featuring software for use in remote computer access for the creation or transmission of audio, video and data related to a medical treatment for diagnostic or clinical use via private cloud computing for medical professionals to work collaboratively; software as a service (SaaS) services featuring software for use in remote computer access for communicating audio, video and data, namely, magnetic resonance images (MRI) and radiotherapy treatment information, between computers via a secure global computer network, wide-area computer networks, and peer-to-peer computer networks; providing a secure, web-based service featuring technology that enables healthcare professionals to simultaneously and collaboratively access, analyze, transmit, and display patient data obtained from a radiotherapy apparatus remotely; providing temporary use of online non-downloadable cloud computing software for use by healthcare professionals to enable the simultaneous and collaborative remote access to on-table adaptive radiotherapy medical apparatus and systems for purposes of directing and modifying radiotherapy treatments, treatment plans, and treatment delivery | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VIEWRAY SYSTEMS, INC.
- Other trademarks owned by VIEWRAY SYSTEMS, INC.
- Other trademarks owned by ViewRay Technologies, Inc.
- Other trademarks owned by ViewRay Technologies, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named MRIDIAN A3I
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 3, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 9, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 9, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 9, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 27, 2026 | IUAF | USE AMENDMENT FILED | — |
| Aug 27, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 9, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 8, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 8, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 23, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Feb 23, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 18, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 18, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 18, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 18, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 18, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 29, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 29, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 29, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 28, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 28, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 28, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 29, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 29, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 29, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 29, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 12, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 12, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 12, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 12, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 12, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 12, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 17, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 17, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 16, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 16, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 16, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 29, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 4, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 4, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 14, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 4, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 1, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 15, 2022 | NWAP | NEW APPLICATION ENTERED | — |